Vitamin D Deficiency Increases Risk of Severe or Fatal COVID-19

Article

COVID-19 patients who were vitamin D deficient before infection were 14 times more likely to have severe or fatal COVID-19 disease.

COVID-19 patients who were vitamin D deficient before infection were 14 times more likely to have severe or fatal COVID-19 disease.

Vitamin D is crucial to maintain bone health and facilitate immune system function. Early in the pandemic, health officials encouraged the public to take vitamin D supplements to boost immune response and potentially protect against COVID-19.

Now, studies are increasingly linking low vitamin D levels to an elevated risk of COVID-19 infection and death. One study, published today in PLOS ONE, is among the first to analyze vitamin D levels prior to COVID-19 infection.

Jointly led by Bar-Ilan University and Galilee Medical Center, the study looked for any correlation between pre-infection serum 25-hydroxyvitamin D (25(OH)D) level and COVID-19 severity and mortality. Investigators analyzed hospital records of individuals admitted to the Galilee Medical Center in Nahariya, Israel from April 7, 2020-February 4, 2021. Included subjects had a positive PCR COVID-19 test and 25(OH)D levels documented 14-730 days prior to their infection.

The investigators grouped patients by disease severity and level of 25(OH)D. Vitamin D levels were categorized as deficient, insufficient, adequate, or high-normal. They determined COVID-19 disease severity using multivariable regression analysis. Utilizing a cosinor model, the investigators isolated the influence of a sinusoidal pattern of seasonal 25(OH)D fluctuations.

Of the 1176 patients included in the study, 253 had a record of their 25(OH)D level before COVID-19 infection. Patients with a vitamin D deficiency, defined as < 20 ng/mL, were 14 times more likely to have severe or fatal COVID-19 disease than patients with 25(OH)D ≥ 40 ng/mL.

Overall, a low vitamin D status was present in 87.4% of patients with severe or critical COVID-19, but only 34.3% of patients with mild to moderate disease were vitamin D deficient. Mortality among patients with sufficient vitamin D was 2.3%, but 25.6% in vitamin D deficient patients.

"This study contributes to a continually evolving body of evidence suggesting that a patient's history of vitamin D deficiency is a predictive risk factor associated with poorer COVID-19 clinical disease course and mortality," said study co-author Michael Edelstein a professor at Bar-Ilan University. "It is still unclear why certain individuals suffer severe consequences of COVID-19 infection while others don’t. Our finding adds a new dimension to solving this puzzle."

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.